Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial.
Hardt K, Vandebosch A, Sadoff J, Le Gars M, Truyers C, Lowson D, Van Dromme I, Vingerhoets J, Kamphuis T, Scheper G, Ruiz-Guiñazú J, Faust SN, Spinner CD, Schuitemaker H, Van Hoof J, Douoguih M, Struyf F; ENSEMBLE2 study group. Hardt K, et al. Lancet Infect Dis. 2022 Dec;22(12):1703-1715. doi: 10.1016/S1473-3099(22)00506-0. Epub 2022 Sep 13. Lancet Infect Dis. 2022. PMID: 36113538 Free PMC article. Clinical Trial.
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer.
Rosellini P, Amintas S, Caumont C, Veillon R, Galland-Girodet S, Cuguillière A, Nguyen L, Domblides C, Gouverneur A, Merlio JP, Bezin J, Girodet PO. Rosellini P, et al. Eur J Cancer. 2022 Sep;172:85-95. doi: 10.1016/j.ejca.2022.05.026. Epub 2022 Jun 24. Eur J Cancer. 2022. PMID: 35759814
First-Line Pharmacotherapies and Survival among Patients Diagnosed with Non-Resectable NSCLC: A Real-Life Setting Study with Gender Prospective.
Spini A, Gini R, Rosellini P, Singier A, Bellan C, Pascucci A, Leoncini L, Mathieu C, Martellucci I, Furiesi F, Giorgi S, Donnini S, Roberto G, Ziche M, Salvo F. Spini A, et al. Among authors: rosellini p. Cancers (Basel). 2021 Dec 5;13(23):6129. doi: 10.3390/cancers13236129. Cancers (Basel). 2021. PMID: 34885238 Free PMC article.
Real-World Utilization of Target- and Immunotherapies for Lung Cancer: A Scoping Review of Studies Based on Routinely Collected Electronic Healthcare Data.
Spini A, Hyeraci G, Bartolini C, Donnini S, Rosellini P, Gini R, Ziche M, Salvo F, Roberto G. Spini A, et al. Among authors: rosellini p. Int J Environ Res Public Health. 2021 Jul 19;18(14):7679. doi: 10.3390/ijerph18147679. Int J Environ Res Public Health. 2021. PMID: 34300130 Free PMC article. Review.
Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.
Francini E, Montagnani F, Nuzzo PV, Gonzalez-Velez M, Alimohamed NS, Rosellini P, Moreno-Candilejo I, Cigliola A, Rubio-Perez J, Crivelli F, Shaw GK, Zhang L, Petrioli R, Bengala C, Francini G, Garcia-Foncillas J, Sweeney CJ, Higano CS, Bryce AH, Harshman LC, Lee-Ying R, Heng DYC. Francini E, et al. Among authors: rosellini p. JAMA Netw Open. 2021 Jul 1;4(7):e2116536. doi: 10.1001/jamanetworkopen.2021.16536. JAMA Netw Open. 2021. PMID: 34292336 Free PMC article.
20 results